Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is the current standard‐of‐care in cases of inoperable early stage non‐small cell lung cancer (ES‐NSCLC). This study aimed to assess the survival outcomes and recurrence patterns after SABR for ES‐NSCLC in a hospital setting. METHODS: A single‐in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaoli, Sun, Yanan, Ye, Ke, Fan, Chengcheng, Wang, Xiaohui, Yang, Yang, Jiao, Ruidi, Ge, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952798/
https://www.ncbi.nlm.nih.gov/pubmed/33529496
http://dx.doi.org/10.1111/1759-7714.13768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952798/
https://www.ncbi.nlm.nih.gov/pubmed/33529496
http://dx.doi.org/10.1111/1759-7714.13768

Ejemplares similares